Eyenovia Revenue vs. Shares Outstanding

EYEN Stock  USD 0.09  0.02  19.18%   
Based on the key profitability measurements obtained from Eyenovia's financial statements, Eyenovia may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Eyenovia's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2015-12-31
Previous Quarter
22.6 K
Current Value
1.6 K
Quarterly Volatility
1.8 M
 
Yuan Drop
 
Covid
At this time, Eyenovia's Price To Sales Ratio is very stable compared to the past year. As of the 26th of November 2024, Days Sales Outstanding is likely to grow to about 56.9 K, though Operating Cash Flow Sales Ratio is likely to grow to (6.9 K). At this time, Eyenovia's Interest Income is very stable compared to the past year. As of the 26th of November 2024, Income Tax Expense is likely to grow to 2.10, though Operating Income is likely to grow to (24.1 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.590.8
Way Down
Slightly volatile
For Eyenovia profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Eyenovia to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Eyenovia utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Eyenovia's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Eyenovia over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyenovia. If investors know Eyenovia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyenovia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.69)
Revenue Per Share
0.001
Quarterly Revenue Growth
4
Return On Assets
(0.93)
Return On Equity
(9.15)
The market value of Eyenovia is measured differently than its book value, which is the value of Eyenovia that is recorded on the company's balance sheet. Investors also form their own opinion of Eyenovia's value that differs from its market value or its book value, called intrinsic value, which is Eyenovia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyenovia's market value can be influenced by many factors that don't directly affect Eyenovia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eyenovia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyenovia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyenovia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Eyenovia Shares Outstanding vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Eyenovia's current stock value. Our valuation model uses many indicators to compare Eyenovia value to that of its competitors to determine the firm's financial worth.
Eyenovia is rated below average in revenue category among its peers. It is rated below average in shares outstanding category among its peers creating about  22,826  of Shares Outstanding per Revenue. At this time, Eyenovia's Total Revenue is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eyenovia's earnings, one of the primary drivers of an investment's value.

Eyenovia Revenue vs. Competition

Eyenovia is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 468.11 Million. Eyenovia adds roughly 3,787 in revenue claiming only tiny portion of equities under Health Care industry.

Eyenovia Shares Outstanding vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Eyenovia

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
3.79 K
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Eyenovia

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
86.44 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Eyenovia Shares Outstanding Comparison

Eyenovia is currently under evaluation in shares outstanding category among its peers.

Eyenovia Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Eyenovia, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Eyenovia will eventually generate negative long term returns. The profitability progress is the general direction of Eyenovia's change in net profit over the period of time. It can combine multiple indicators of Eyenovia, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Interest Income547.6 K574.9 K
Operating Income-25.4 M-24.1 M
Net Loss-25.4 M-24.1 M
Income Before Tax-27.3 M-25.9 M
Total Other Income Expense Net-1.9 M-1.8 M
Net Loss-11.5 M-12.1 M
Net Loss-27.3 M-25.9 M
Income Tax Expense 2.00  2.10 
Net Interest Income-2 M-1.9 M
Non Operating Income Net Other2.1 K1.9 K
Change To Netincome2.7 M1.6 M
Net Loss(0.66)(0.70)
Income Quality 0.87  0.72 
Net Income Per E B T 0.89  0.80 

Eyenovia Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Eyenovia. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Eyenovia position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Eyenovia's important profitability drivers and their relationship over time.

Use Eyenovia in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eyenovia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will appreciate offsetting losses from the drop in the long position's value.

Eyenovia Pair Trading

Eyenovia Pair Trading Analysis

The ability to find closely correlated positions to Eyenovia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eyenovia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eyenovia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eyenovia to buy it.
The correlation of Eyenovia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eyenovia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eyenovia moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eyenovia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Eyenovia position

In addition to having Eyenovia in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Food Products Thematic Idea Now

Food Products
Food Products Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Food Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Food Products Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Eyenovia offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eyenovia's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eyenovia Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eyenovia Stock:
Check out Investing Opportunities.
To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
To fully project Eyenovia's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Eyenovia at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Eyenovia's income statement, its balance sheet, and the statement of cash flows.
Potential Eyenovia investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Eyenovia investors may work on each financial statement separately, they are all related. The changes in Eyenovia's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Eyenovia's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.